Whan In Pharm Co.,Ltd.

KSE 016580.KS

Whan In Pharm Co.,Ltd. Operating Income for the year ending December 31, 2023: USD 24.98 M

Whan In Pharm Co.,Ltd. Operating Income is USD 24.98 M for the year ending December 31, 2023, a 6.07% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Whan In Pharm Co.,Ltd. Operating Income for the year ending December 31, 2022 was USD 23.55 M, a -10.04% change year over year.
Whan In Pharm Co.,Ltd. Operating Income for the year ending December 31, 2021 was USD 26.18 M, a 0.34% change year over year.
Whan In Pharm Co.,Ltd. Operating Income for the year ending December 31, 2020 was USD 26.09 M, a 15.67% change year over year.
Whan In Pharm Co.,Ltd. Operating Income for the year ending December 31, 2019 was USD 22.55 M, a -7.73% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

KSE: 016580.KS

Whan In Pharm Co.,Ltd.

CEO	Mr. Wonbum Lee
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Whanin Building, 11
Employees	582
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years